Board of Directors
Board experience spanning biotechnology, radiopharmaceuticals, oncology, drug development, transactions and capital markets.
Board
Kirsten Drejer
Chair of the Board
Biography
Biotechnology entrepreneur and experienced board leader. Co-founder and former CEO of Symphogen, with extensive experience in oncology drug development, financing and strategic partnerships.
Andreas Kjær
Co-founder, CSO & Deputy Chair of the Board
Biography
Physician-scientist and molecular imaging and Theranostics specialist whose research underpins Curasight’s uPAR platform.
Ulrich Krasilnikoff
Board member, CEO
Biography
Executive with experience across biotechnology, finance, private equity and corporate development.
Marcel Reichen
Board member
Biography
Radioligand therapy strategy and business development executive with prior leadership roles at Novartis / Advanced Accelerator Applications and current experience at Ratio Therapeutics.
Dr. Colin Hayward
Board member
Biography
Physician and radiopharmaceutical development executive, formerly Chief Medical Officer of Telix Pharmaceuticals, with broad oncology and clinical development experience.
